Tel Aviv, Israel

Moshe Havilio

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Moshe Havilio

Introduction

Moshe Havilio is a prominent inventor based in Tel Aviv, Israel. He is known for his significant contributions to the field of medical imaging, particularly in the monitoring of retinal diseases. His innovative approach has led to advancements that enhance the understanding and treatment of these conditions.

Latest Patents

Havilio holds a patent for an OCT guided therapy system. This system and its associated method focus on monitoring the state of a subject's retinal disease through remote-based optical coherence tomography (OCT) imaging. The method involves receiving OCT image data of a subject's retina during a series of imaging sessions. The data is then processed to determine a series of measured extent values, each indicative of the extent of the retinal disease. This patent represents a significant step forward in the management of retinal conditions.

Career Highlights

Throughout his career, Moshe Havilio has made notable strides in the field of medical technology. His work at Notal Vision Inc. has positioned him as a leader in the development of innovative solutions for retinal disease monitoring. His expertise and dedication to improving patient outcomes have earned him recognition in the industry.

Collaborations

Havilio has collaborated with several talented professionals, including Amit Pascal and Kester Nahen. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Moshe Havilio's contributions to the field of medical imaging and retinal disease monitoring are invaluable. His patent for OCT guided therapy exemplifies his commitment to advancing healthcare technology. Through his work, he continues to make a significant impact on the lives of patients suffering from retinal diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…